FDA rejects InterMune’s drug for fatal lung disease
The Food and Drug Administration have announced that they have rejected the company behind a new drug that was developed to treat the fatal lung disease known as Forest lung disease. InterMune, Inc. was the company behind the drug which the FDA turned down stating that there were too many negative side effects to the [...]
